SCHEMBL18973007

SCHEMBL18973007

CC(=O)NC12CCC3C(C(=O)C=C4C5(C)C=C(C#N)C(=O)C(C)C5CCC43C)C1CC(C)(C)CC2

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ MBOAT4 Q96T53 4/20 0.39
▸ NFE2L2 Q16236 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ STAT3 P40763 1/20 0.38
▸ USP7 Q93009 1/20 0.38
▸ NOS2 P35228 7/20 0.38
▸ KEAP1 Q14145 1/20 0.38
▸ RORC P51449 6/20 0.38
▸ CCR6 P51684 1/20 0.34
▸ IDH1 O75874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23098226 0.92 MBOAT4 (0.41) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL18972899 0.91 MBOAT4 (0.40) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL22875356 0.90 MBOAT4 (0.39) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL21022599 0.90 MBOAT4 (0.39) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL22875560 0.90 MBOAT4 (0.39) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL20750868 0.86 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL20826204 0.86 NOS2 (0.39) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL23464592 0.85 RORC (0.36) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL22875550 0.85 MBOAT4 (0.37) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2
SCHEMBL24511981 0.84 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19MBOAT4NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841445-B1 2.2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF REATA PHARMACEUTICALS INC (US) 2017-06-14 — — EP disclosed
Send feedback